{"id":"generic-b","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Dizziness"},{"rate":"10-20%","effect":"Fatigue"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Cold extremities"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Generic B is a non-selective beta-blocker that competes with epinephrine for binding sites on beta-adrenergic receptors in the heart, smooth muscle, and other tissues. This results in decreased heart rate, reduced cardiac output, and decreased peripheral vascular resistance. By reducing the workload on the heart, Generic B can help to alleviate symptoms of angina and reduce the risk of heart attack.","oneSentence":"Generic B is a beta-blocker that works by blocking the effects of the hormone epinephrine, also known as adrenaline, and slowing the heart rate and reducing its workload.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:31:11.644Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Angina pectoris"},{"name":"Heart failure"}]},"trialDetails":[{"nctId":"NCT07493291","phase":"","title":"Effectiveness and Safety of Palbociclib: Brand vs. Generic in Iraqi Stage IV Hormone Receptor-positive / Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer Patients: A Comparative Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Al-Mustansiriyah University","startDate":"2025-09-07","conditions":"Brest Cancer","enrollment":100},{"nctId":"NCT07105007","phase":"NA","title":"Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV","status":"RECRUITING","sponsor":"University of Washington","startDate":"2025-08-15","conditions":"HIV, Heart Failure","enrollment":30},{"nctId":"NCT06596434","phase":"PHASE2","title":"4-Aminopyridine to Treat Skin Burns","status":"RECRUITING","sponsor":"John Elfar","startDate":"2026-01-01","conditions":"Burns, Second Degree Burn, Wounds and Injuries","enrollment":200},{"nctId":"NCT07366463","phase":"NA","title":"Integrating Hepatological, Nutritional, and Psychological Support as a Multidisciplinary Management to Improve Long-term Clinical Outcomes in MASLD","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2023-07-01","conditions":"MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD, Cardiovascular Events","enrollment":286},{"nctId":"NCT04913220","phase":"PHASE1, PHASE2","title":"A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201)","status":"TERMINATED","sponsor":"Sanofi","startDate":"2021-07-15","conditions":"Malignant Melanoma, Squamous Cell Carcinoma of Skin","enrollment":46},{"nctId":"NCT06040255","phase":"PHASE4","title":"Focal Cerebral Arteriopathy Steroid Trial","status":"ENROLLING_BY_INVITATION","sponsor":"University of California, San Francisco","startDate":"2023-10-01","conditions":"Pediatric Stroke, Arteriopathy, Arterial Ischemic Stroke","enrollment":80},{"nctId":"NCT04784585","phase":"NA","title":"Miro-randomized Trial for Optimizing a JITAI to Reduce Dietary Lapses in Obesity Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Miriam Hospital","startDate":"2021-10-26","conditions":"Obesity","enrollment":204},{"nctId":"NCT05179603","phase":"PHASE2","title":"A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205]","status":"TERMINATED","sponsor":"Sanofi","startDate":"2021-12-07","conditions":"Classic Hodgkin Lymphoma, Diffuse Large B-cell Lymphoma","enrollment":14},{"nctId":"NCT03701581","phase":"PHASE2, PHASE3","title":"4-aminopyridine Treatment for Nerve Injury","status":"RECRUITING","sponsor":"John Elfar","startDate":"2021-06-05","conditions":"Nerve Injury, Prostate Cancer","enrollment":70},{"nctId":"NCT06333171","phase":"PHASE2","title":"4-aminopyridine for Skin Wound Healing","status":"RECRUITING","sponsor":"John Elfar","startDate":"2025-09","conditions":"Wounds, Wound of Skin, Wound Heal","enrollment":150},{"nctId":"NCT07085728","phase":"PHASE2","title":"Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure","status":"NOT_YET_RECRUITING","sponsor":"Eastern Cooperative Oncology Group","startDate":"2025-08-11","conditions":"Myeloma Multiple","enrollment":74},{"nctId":"NCT05540470","phase":"NA","title":"Radical CUREfor MAlaria Among Highly Mobile and Hard-to-reach Populations in the Guyanese Shield","status":"COMPLETED","sponsor":"Centre Hospitalier de Cayenne","startDate":"2022-09-12","conditions":"Malaria, Vivax","enrollment":1991},{"nctId":"NCT03299348","phase":"NA","title":"AgingPLUS: Promoting Physical Activity in Adults","status":"COMPLETED","sponsor":"Colorado State University","startDate":"2018-05-01","conditions":"Physical Activity","enrollment":402},{"nctId":"NCT06465498","phase":"NA","title":"Investigating ACute HeArt FailuRe Decongestion Guided by Lung UltraSonography","status":"RECRUITING","sponsor":"Antonio Leidi","startDate":"2024-10-22","conditions":"Acute Heart Failure","enrollment":222},{"nctId":"NCT05815030","phase":"NA","title":"HIV Pre-Exposure Prophylaxis Among an Unrecognized Sexual Minority Population","status":"TERMINATED","sponsor":"The Alternative Sexualities Health Research Alliance","startDate":"2023-04-11","conditions":"Pre-Exposure Prophylaxis","enrollment":57},{"nctId":"NCT05886998","phase":"PHASE3","title":"Nebulized Heparin for Prevention of Acute Lung Injury in Smoke Inhalation Injury","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-06-01","conditions":"Smoke Inhalation Injury, Acute Lung Injury","enrollment":88},{"nctId":"NCT05394779","phase":"NA","title":"DEMETRA - ADVICE-002-2022","status":"COMPLETED","sponsor":"Advice Pharma Group srl","startDate":"2022-08-23","conditions":"Obesity, Health Behavior, Life Style","enrollment":246},{"nctId":"NCT00894556","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2009-06-10","conditions":"Acute Migraine","enrollment":109},{"nctId":"NCT06360445","phase":"PHASE1","title":"Bioequivalence Study of Olaparib Tablets Under Fasting and Fed Conditions in Healthy Subjects","status":"COMPLETED","sponsor":"CSPC Ouyi Pharmaceutical Co., Ltd.","startDate":"2022-05-26","conditions":"Healthy Participants","enrollment":102},{"nctId":"NCT04633083","phase":"NA","title":"Range-of-motion Analysis of Reverse Shoulder Arthroplasty","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2019-03-20","conditions":"Shoulder Impingement","enrollment":18},{"nctId":"NCT01156129","phase":"PHASE1","title":"Interventions to Decrease the Impact of Post-OPerative Ileus After Liver Transplant or Resection Surgery","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2010-09-01","conditions":"Ileus","enrollment":111},{"nctId":"NCT05934656","phase":"","title":"Understanding Gut Symptoms in People With Cystic Fibrosis","status":"RECRUITING","sponsor":"University of Nottingham","startDate":"2023-06-26","conditions":"Cystic Fibrosis, Gastrointestinal Dysfunction","enrollment":350},{"nctId":"NCT03875885","phase":"NA","title":"CONNECTing Head and Neck Caregivers to Supportive Care Resources","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2020-09-16","conditions":"Head and Neck Cancer","enrollment":40},{"nctId":"NCT05492851","phase":"PHASE4","title":"Trial Comparing Three Single Dose Injections for Knee Osteoarthritis","status":"TERMINATED","sponsor":"Ohio State University","startDate":"2022-08-02","conditions":"Osteoarthritis, Knee","enrollment":6},{"nctId":"NCT02660710","phase":"PHASE2","title":"Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma","status":"COMPLETED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2016-03","conditions":"Diffuse Large B-cell Lymphoma, HIV","enrollment":39},{"nctId":"NCT05534997","phase":"NA","title":"Rehabilitation Therapy for Post COVID 19 Chronic Fatigue Syndrome","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2022-10-01","conditions":"Post-COVID-19 Syndrome","enrollment":60},{"nctId":"NCT05254808","phase":"PHASE3","title":"EXtended Use of FOsfomycin for the Treatment of CYstitis in Primary Care","status":"TERMINATED","sponsor":"MJM Bonten","startDate":"2021-09-06","conditions":"Urinary Tract Infections","enrollment":13},{"nctId":"NCT05265676","phase":"PHASE1","title":"Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human Subjects","status":"COMPLETED","sponsor":"Venus Remedies Limited","startDate":"2021-02-26","conditions":"Healthy","enrollment":24},{"nctId":"NCT00790829","phase":"NA","title":"Preemptive Use of the Nicotine Patch for Postoperative Pain Relief After Open Abdominal Surgery","status":"TERMINATED","sponsor":"Stony Brook University","startDate":"2007-08","conditions":"Postoperative Pain","enrollment":30},{"nctId":"NCT05128175","phase":"PHASE1","title":"Comparative Bioavailability Study of Carbidopa/Levodopa Extended-Release Tablets Under Fasting and Fed Conditions","status":"UNKNOWN","sponsor":"Shanghai WD Pharmaceutical Co., Ltd.","startDate":"2021-10-29","conditions":"Parkinson Disease","enrollment":15},{"nctId":"NCT05125575","phase":"PHASE1","title":"Fed Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunteers","status":"COMPLETED","sponsor":"Joint Stock Company \"Farmak\"","startDate":"2019-01-11","conditions":"Pharmacokinetics","enrollment":28},{"nctId":"NCT05124717","phase":"PHASE1","title":"Fed Bioequivalence Study of 2 Metformin 500 mg Prolongued Release Tablets in 28 Healthy Male and Female Volunteers","status":"COMPLETED","sponsor":"Joint Stock Company \"Farmak\"","startDate":"2019-06-25","conditions":"Pharmacokinetics","enrollment":28},{"nctId":"NCT05124730","phase":"PHASE1","title":"Fasting Bioequivalence Study of 2 Metformin 500 mg Prolonged Release Tablets in 44 Healthy Male and Female Volunteers","status":"COMPLETED","sponsor":"Joint Stock Company \"Farmak\"","startDate":"2021-05-21","conditions":"Pharmacokinetics","enrollment":44},{"nctId":"NCT05125588","phase":"PHASE1","title":"Fasting Comparative Bioavailability Study of 2 Meloxicam 15 mg Tablets in Healthy Volunteers Under Fasting Condition","status":"COMPLETED","sponsor":"Joint Stock Company \"Farmak\"","startDate":"2014-01-29","conditions":"Pharmacokinetics","enrollment":24},{"nctId":"NCT05125640","phase":"PHASE1","title":"Fasting Bioequivalence Study of 2 Oral Progesterone Soft Capsules 200 mg in 48 Healthy Female Subjects","status":"COMPLETED","sponsor":"Joint Stock Company \"Farmak\"","startDate":"2019-12-13","conditions":"Pharmacokinetics","enrollment":48},{"nctId":"NCT05125549","phase":"PHASE1","title":"Fasted Bioequivalence Study of Clopidogrel Film-coated Tablets, 75 mg in 48 Healthy, Adult Male and Female Subjects.","status":"COMPLETED","sponsor":"Joint Stock Company \"Farmak\"","startDate":"2018-07-12","conditions":"Pharmacokinetics","enrollment":48},{"nctId":"NCT05125627","phase":"PHASE1","title":"Fasting Bioequivalence Study of 2 Progesterone Soft Capsules 200 mg in 66 Healthy Female Subjects Under Vaginal Route","status":"COMPLETED","sponsor":"Joint Stock Company \"Farmak\"","startDate":"2019-08-28","conditions":"Pharmacokinetics","enrollment":66},{"nctId":"NCT05123976","phase":"PHASE1","title":"Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subjects.","status":"COMPLETED","sponsor":"Joint Stock Company \"Farmak\"","startDate":"2020-10-21","conditions":"Pharmacokinetics","enrollment":32},{"nctId":"NCT05123781","phase":"PHASE1","title":"Fasting Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunteers","status":"COMPLETED","sponsor":"Joint Stock Company \"Farmak\"","startDate":"2019-04-03","conditions":"Pharmacokinetics","enrollment":28},{"nctId":"NCT03021863","phase":"NA","title":"How Frequently and in What Format Are Research Trial Results Disseminated to Participants (ResponseQT)","status":"COMPLETED","sponsor":"ThinkWell","startDate":"2017-01-15","conditions":"Motivation","enrollment":1198},{"nctId":"NCT02734862","phase":"PHASE2","title":"CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension","status":"COMPLETED","sponsor":"Cidara Therapeutics Inc.","startDate":"2016-07-26","conditions":"Candidemia, Mycoses, Fungal Infection","enrollment":207},{"nctId":"NCT00665951","phase":"PHASE1","title":"Pharmacokinetic Study of Two Generic Co-formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2008-09","conditions":"HIV Infections","enrollment":12},{"nctId":"NCT03130998","phase":"NA","title":"Cluster Randomized Trial of Knowledge Brokering to Integrate Mood and Smoking Cessation in Ontario Primary Care","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2018-02-27","conditions":"Depression","enrollment":2765},{"nctId":"NCT03068754","phase":"PHASE2, PHASE3","title":"Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS)","status":"TERMINATED","sponsor":"Mallinckrodt","startDate":"2017-06-22","conditions":"Amyotrophic Lateral Sclerosis","enrollment":143},{"nctId":"NCT03992742","phase":"NA","title":"Building Capacity and Promoting Smoking Cessation in the Community Via \"Quit to Win\" Contest 2019","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2019-06-21","conditions":"Smoking Cessation","enrollment":1200},{"nctId":"NCT00750009","phase":"PHASE3","title":"Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2008-04","conditions":"Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, Leukemia","enrollment":583},{"nctId":"NCT04069858","phase":"PHASE4","title":"Maintaining Antiviral Efficacy After Switching to Generic Entecavir 1 mg for Chronic Hepatitis B","status":"UNKNOWN","sponsor":"Korea University","startDate":"2016-12-01","conditions":"Chronic Hepatitis B","enrollment":40},{"nctId":"NCT02417246","phase":"PHASE4","title":"Open-Labeled PK-PD Studies of Metoprolol ER","status":"COMPLETED","sponsor":"University of Florida","startDate":"2015-08","conditions":"Blood Pressure","enrollment":61},{"nctId":"NCT04184739","phase":"NA","title":"Quality and Effectiveness of a Personalised App to Support Patients With Fixed Braces","status":"UNKNOWN","sponsor":"University College, London","startDate":"2020-10","conditions":"Treatment Adherence and Compliance","enrollment":138},{"nctId":"NCT03082352","phase":"PHASE1","title":"Clinical Bioequivalence Study on Two Metoprolol Tablet 100mg Formulations","status":"UNKNOWN","sponsor":"Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited","startDate":"2020-08","conditions":"Healthy","enrollment":30},{"nctId":"NCT02726789","phase":"PHASE2","title":"Combination Treatment With REP 2139-Ca and Pegasys in Patients With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Replicor Inc.","startDate":"2012-10","conditions":"Hepatitis B, Chronic","enrollment":5},{"nctId":"NCT03599466","phase":"PHASE1","title":"Clinical Bioequivalence Study on Two Lisinopril Tablets 20mg Formulations","status":"UNKNOWN","sponsor":"Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited","startDate":"2019-10","conditions":"Healthy","enrollment":30},{"nctId":"NCT03655457","phase":"NA","title":"Evaluation of the Efficacy of Surfaktant in Preterm Infants by Lung Ultrasound","status":"UNKNOWN","sponsor":"Zekai Tahir Burak Women's Health Research and Education Hospital","startDate":"2018-03-21","conditions":"Lung Ultrasound Scores","enrollment":64},{"nctId":"NCT03546985","phase":"NA","title":"A Trial of Episil® Oral Liquid in Cancer Patients Suffering From Chemotherapy- and/or Radiation-induced Oral Mucositis","status":"COMPLETED","sponsor":"Solasia Pharma K.K.","startDate":"2017-12-26","conditions":"Chemotherapy- and/or Radiation-induced Oral Mucositis","enrollment":60},{"nctId":"NCT02216123","phase":"PHASE3","title":"Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-04-30","conditions":"Malaria, Vivax","enrollment":251},{"nctId":"NCT01709708","phase":"PHASE4","title":"Use of the Tx360 Nasal Applicator in the Treatment of Chronic Migraine","status":"COMPLETED","sponsor":"Tian Medical Inc.","startDate":"2012-09","conditions":"Chronic Migraine","enrollment":41},{"nctId":"NCT03210025","phase":"PHASE1","title":"Clinical Bioequivalence Study on Two Methyldopa Tablet 250mg Formulations","status":"COMPLETED","sponsor":"Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited","startDate":"2017-09-20","conditions":"Healthy","enrollment":17},{"nctId":"NCT03250910","phase":"PHASE4","title":"Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2016-08-01","conditions":"Hepatitis C Virus Infection, Response to Therapy of, Human Immunodeficiency Virus","enrollment":228},{"nctId":"NCT01873573","phase":"NA","title":"Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2013-07-18","conditions":"Dysphagia","enrollment":10},{"nctId":"NCT02635438","phase":"PHASE3","title":"A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal Candidiasis.","status":"UNKNOWN","sponsor":"Thinq Pharma-CRO Pte. Ltd.","startDate":"2016-12","conditions":"Oropharyngeal Candidiasis","enrollment":360},{"nctId":"NCT01733394","phase":"PHASE4","title":"Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2012-12-12","conditions":"Epilepsy","enrollment":54},{"nctId":"NCT02368899","phase":"NA","title":"Computerized Alcohol Misuse Intervention System for Health Care","status":"COMPLETED","sponsor":"Research Circle Associates, LLC","startDate":"2016-11","conditions":"Alcoholism","enrollment":61},{"nctId":"NCT03019614","phase":"PHASE1","title":"An Open Label Study in Healthy Volunteers to Compare Chronocort® to Hydrocortisone","status":"COMPLETED","sponsor":"Neurocrine UK Limited","startDate":"2010-03","conditions":"Congenital Adrenal Hyperplasia, Adrenal Insufficiency","enrollment":30},{"nctId":"NCT02017197","phase":"PHASE4","title":"Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2014-08","conditions":"Atrial Fibrillation","enrollment":100},{"nctId":"NCT02707913","phase":"PHASE1","title":"Clinical Bioequivalence Study on Two Amlodipine Tablet 10mg Formulations","status":"COMPLETED","sponsor":"Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited","startDate":"2016-03","conditions":"Healthy","enrollment":17},{"nctId":"NCT01217632","phase":"PHASE2","title":"A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection","status":"TERMINATED","sponsor":"Kyntra Bio","startDate":"2010-08","conditions":"Liver Fibrosis Due to Chronic Hepatitis B Infection","enrollment":114},{"nctId":"NCT02643329","phase":"PHASE1","title":"Clinical Bioequivalence Study on Two Gliclazide 80mg Tablet Formulations","status":"COMPLETED","sponsor":"Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited","startDate":"2016-01","conditions":"Healthy","enrollment":17},{"nctId":"NCT02185534","phase":"PHASE1","title":"Clopidogrel Bioequivalence Study in Healthy Subjects","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-08","conditions":"Bioequivalence, AUC, Cmax, Pharmacokinetics","enrollment":144},{"nctId":"NCT01438710","phase":"PHASE3","title":"Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)","status":"COMPLETED","sponsor":"Veloxis Pharmaceuticals","startDate":"2011-12","conditions":"Renal Failure, Tremors","enrollment":44},{"nctId":"NCT01713777","phase":"PHASE4","title":"Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2013-04","conditions":"Epilepsy","enrollment":35},{"nctId":"NCT01344070","phase":"NA","title":"Generic Formulations of Commonly-used Oral Drugs in Saudi Arabia:Interchangeability & Post-marketing Quality","status":"COMPLETED","sponsor":"King Faisal Specialist Hospital & Research Center","startDate":"2011-04","conditions":"Generic Drug Quality, Generic Formulation Interchangeability","enrollment":500},{"nctId":"NCT00622141","phase":"PHASE1, PHASE2","title":"Bioequivalence Study of Generic GPO Saquinavir and Norvir® Versus Invirase® and Norvir®","status":"WITHDRAWN","sponsor":"The HIV Netherlands Australia Thailand Research Collaboration","startDate":"","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT02327663","phase":"PHASE4","title":"Emtricitabine for Naive Chinese Chronic Hepatitis B Patients","status":"UNKNOWN","sponsor":"Asian-Pacific Alliance of Liver Disease, Beijing","startDate":"2014-12","conditions":"Hepatitis B, Chronic","enrollment":2000},{"nctId":"NCT02327689","phase":"PHASE4","title":"Emtricitabine Plus Adefovir Dipivoxil for Naive Chinese HBV Related Cirrhosis Patients","status":"UNKNOWN","sponsor":"Asian-Pacific Alliance of Liver Disease, Beijing","startDate":"2015-01","conditions":"Hepatitis B, Chronic, Fibrosis","enrollment":400},{"nctId":"NCT02327676","phase":"PHASE4","title":"Emtricitabine for Naive Child Chinese Chronic Hepatitis B Patients","status":"UNKNOWN","sponsor":"Asian-Pacific Alliance of Liver Disease, Beijing","startDate":"2015-01","conditions":"Hepatitis B, Chronic","enrollment":200},{"nctId":"NCT01841593","phase":"PHASE1","title":"A Two Way Cross Over Pharmacokinetic Interaction Study Between Raltegravir and Amlodipine in Healthy Volunteers","status":"COMPLETED","sponsor":"St Stephens Aids Trust","startDate":"2013-04","conditions":"HIV","enrollment":19},{"nctId":"NCT01119742","phase":"PHASE1","title":"Clinical Equivalence of Two Generic Butenafine Hydrochloride 1% Creams as Compared to Lotrimin Ultra Cream in Patients With Interdigital Tinea Pedis","status":"TERMINATED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2010-07","conditions":"Interdigital Tinea Pedis","enrollment":428},{"nctId":"NCT01652859","phase":"PHASE1","title":"An Bioequivalence Study to Compare Two 2 mg/ml Liposomal Amphotericin B Injections in Healthy Subjects","status":"COMPLETED","sponsor":"Taiwan Liposome Company","startDate":"2012-02","conditions":"Normal Healthy Subjects","enrollment":36},{"nctId":"NCT01341743","phase":"PHASE4","title":"Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2010-12","conditions":"Hepatitis B","enrollment":360},{"nctId":"NCT01898676","phase":"PHASE1","title":"A Study in Stable Epilepsy Patients Comparing Brand and Generic Divalproex Sodium Extended Release Tablets","status":"UNKNOWN","sponsor":"Vince & Associates Clinical Research, Inc.","startDate":"2013-07","conditions":"Epilepsy","enrollment":16},{"nctId":"NCT01792063","phase":"PHASE4","title":"Two Different Preparations of Sevoflurane in Induction","status":"COMPLETED","sponsor":"Istanbul University","startDate":"2013-02","conditions":"Coughing on Induction, Vapors; Inhalation","enrollment":200},{"nctId":"NCT01833611","phase":"PHASE4","title":"Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALT","status":"UNKNOWN","sponsor":"National Cheng-Kung University Hospital","startDate":"2008-09","conditions":"Chronic Hepatitis","enrollment":130},{"nctId":"NCT01255371","phase":"PHASE3","title":"A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir","status":"WITHDRAWN","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2012-03","conditions":"HIV","enrollment":""},{"nctId":"NCT01582555","phase":"NA","title":"Postoperative Nasal Irrigation Using Mucolytic Agents","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2012-06","conditions":"Surgical Procedure, Unspecified","enrollment":44},{"nctId":"NCT01440621","phase":"PHASE3","title":"Modafinil in Cancer Related Fatigue","status":"COMPLETED","sponsor":"Indira Gandhi Medical College, Shimla","startDate":"2010-08","conditions":"Cancer Related Fatigue, Quality of Life","enrollment":217},{"nctId":"NCT01220596","phase":"PHASE3","title":"Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.","status":"UNKNOWN","sponsor":"Hanyang University","startDate":"2010-06","conditions":"Hepatitis B, Chronic","enrollment":228},{"nctId":"NCT00618176","phase":"PHASE4","title":"Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation Cohort","status":"COMPLETED","sponsor":"Peking Union Medical College","startDate":"2005-01","conditions":"HIV Infections","enrollment":198}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Metoprolol extended-release (ER)"],"phase":"marketed","status":"active","brandName":"Generic B","genericName":"Generic B","companyName":"University of Florida","companyId":"university-of-florida","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Generic B is a beta-blocker that works by blocking the effects of the hormone epinephrine, also known as adrenaline, and slowing the heart rate and reducing its workload. Used for Hypertension, Angina pectoris, Heart failure.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}